Founder
Gabe Ling Founder
Spent COVID learning the Grieg Piano Concerto, and performed in a sold out concert with the Aula Symfonia Jakarta in 2022.
Gabe is the Co-Founder and Managing Director of M33 Growth. M33 invests in emerging technology and healthcare companies and partners with founders to rapidly grow their businesses. Gabe has led investments in companies including The Oncology Institute (NASDAQ: TOI), Acclivity Health, Dependable Health Services, YAPI, and RHI Group.
Before starting M33 Growth, he was a Partner at General Catalyst, a leading venture capital firm where he spent over a decade helping entrepreneurs build their companies. He served on several boards, including Datalogix (acquired by Oracle), CLEAResult (acquired by General Atlantic), Oceans Healthcare (acquired by Webster Capital), OGSystems (acquired by Parsons), and Brighter (acquired by Cigna).
Prior to General Catalyst, Gabe attended Yale University, where he graduated magna cum laude with a B.A. in Economics and worked at the Yale Investments Office under the mentorship of David Swensen and Dean Takahashi. He was recognized by the Greater Boston Chamber of Commerce as a recipient of the Ten Outstanding Young Leaders (TOYL) award for civic and business leadership and is an alumnus of Harvard Business School’s Young American Leaders Program, which convenes leaders from around the country to foster cross-sector collaborations that impact local communities. Gabe currently serves on the Board of Trustees of Park Street School and the Board of Advisors of the Boston Symphony Orchestra. Gabe is also a concert pianist, and has appeared as a soloist with the Florida Orchestra and the Jakarta Simfonia Orchestra.
